Prime Medicine, Inc. (PRME) stock
PRMENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$4.27+0.38 (+9.77%)
Close on Nov 13, 2026Market cap $774.48MP/E –Yield –
Prime Medicine total assets
Total assets on the balance sheet at the end of each period.
Prime Medicine's total assets was $213.86M at Sep 30, 2026. For fiscal 2025 it was $342.73M, up 15.2% from the year before. The highest annual figure on record is $360.31M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $342.73M | +15.2% |
| FY2024 | Dec 31, 2024 | $297.51M | +53.5% |
| FY2023 | Dec 31, 2023 | $193.85M | -46.2% |
| FY2022 | Dec 31, 2022 | $360.31M | +19.4% |
| FY2021 | Dec 31, 2021 | $301.86M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $213.86M | -44.5% |
| Q2 FY2026 | Jun 30, 2026 | $249.04M | -10.7% |
| Q1 FY2026 | Mar 31, 2026 | $294.73M | -10.2% |
| Q4 FY2025 | Dec 31, 2025 | $342.73M | +15.2% |
| Q3 FY2025 | Sep 30, 2025 | $385.01M | +15.7% |
| Q2 FY2025 | Jun 30, 2025 | $279.01M | +7.4% |
| Q1 FY2025 | Mar 31, 2025 | $328.16M | +5.4% |
| Q4 FY2024 | Dec 31, 2024 | $297.51M | +53.5% |
| Q3 FY2024 | Sep 30, 2024 | $332.78M | +39.2% |
| Q2 FY2024 | Jun 30, 2024 | $259.71M | -7.5% |
| Q1 FY2024 | Mar 31, 2024 | $311.38M | -1.8% |
| Q4 FY2023 | Dec 31, 2023 | $193.85M | -46.2% |
| Q3 FY2023 | Sep 30, 2023 | $239.15M | +11.1% |
| Q2 FY2023 | Jun 30, 2023 | $280.87M | -7.0% |
| Q1 FY2023 | Mar 31, 2023 | $316.95M | – |
| Q4 FY2022 | Dec 31, 2022 | $360.31M | – |
| Q3 FY2022 | Sep 30, 2022 | $215.27M | – |
| Q4 FY2021 | Dec 31, 2021 | $301.86M | – |
See a number that looks wrong?